OBJECTIVES/HYPOTHESIS: Advances in bone repair have focused on the minimally-invasive delivery of tissue-engineered bone (TEB). A promising injectable biopolymer of chitosan and inorganic phosphates was seeded with mesenchymal stem cells (MSCs) and a bone growth factor (BMP-2), and evaluated in a rat calvarial critical size defect (CSD). Green fluorescent protein (GFP)-labeled MSCs are used to evaluate patterns of cell viability and proliferation. STUDY DESIGN: Prospective, controlled trial in an animal model. METHODS: In 30 male rats, 8-mm calvarial CSDs were created, and divided into five groups of six animals each. In the experimental groups, the defects were injected with either chitosan gel, gel loaded with MSCs (0.3 x 10(6) cells/defect), gel loaded with BMP-2 (2 microg/defect), or gel loaded with both MSC and BMP-2. In the control group, the defect was left untreated. At 4 weeks, in vivo microcomputed tomography (micro-CT) analysis was performed. At 8 weeks, calvarial specimens were examined by micro-CT, histology, and immunohistochemistry. RESULTS: New areas of bone growth were seen in the defects of all treated animals. Micro-CT analysis revealed a significant (P < .001) time-dependent increase in the regeneration of bone volume and bone area in defects treated with gel/MSC/BMP-2 as compared to all other groups. Histological analysis confirmed this difference. GFP-labeled TEB was detected within the areas of new bone, indicating cell viability and contribution to new bone growth by the injected MSC. CONCLUSIONS: This study demonstrates that an injectable form of TEB using a chitosan gel, MSC, and BMP-2 can enhance bone formation in a rat calvarial CSD.
OBJECTIVES/HYPOTHESIS: Advances in bone repair have focused on the minimally-invasive delivery of tissue-engineered bone (TEB). A promising injectable biopolymer of chitosan and inorganic phosphates was seeded with mesenchymal stem cells (MSCs) and a bone growth factor (BMP-2), and evaluated in a rat calvarial critical size defect (CSD). Green fluorescent protein (GFP)-labeled MSCs are used to evaluate patterns of cell viability and proliferation. STUDY DESIGN: Prospective, controlled trial in an animal model. METHODS: In 30 male rats, 8-mm calvarial CSDs were created, and divided into five groups of six animals each. In the experimental groups, the defects were injected with either chitosan gel, gel loaded with MSCs (0.3 x 10(6) cells/defect), gel loaded with BMP-2 (2 microg/defect), or gel loaded with both MSC and BMP-2. In the control group, the defect was left untreated. At 4 weeks, in vivo microcomputed tomography (micro-CT) analysis was performed. At 8 weeks, calvarial specimens were examined by micro-CT, histology, and immunohistochemistry. RESULTS: New areas of bone growth were seen in the defects of all treated animals. Micro-CT analysis revealed a significant (P < .001) time-dependent increase in the regeneration of bone volume and bone area in defects treated with gel/MSC/BMP-2 as compared to all other groups. Histological analysis confirmed this difference. GFP-labeled TEB was detected within the areas of new bone, indicating cell viability and contribution to new bone growth by the injected MSC. CONCLUSIONS: This study demonstrates that an injectable form of TEB using a chitosan gel, MSC, and BMP-2 can enhance bone formation in a rat calvarialCSD.
Authors: M Ishihara; K Ono; M Sato; K Nakanishi; Y Saito; H Yura; T Matsui; H Hattori; M Fujita; M Kikuchi; A Kurita Journal: Wound Repair Regen Date: 2001 Nov-Dec Impact factor: 3.617
Authors: H Petite; V Viateau; W Bensaïd; A Meunier; C de Pollak; M Bourguignon; K Oudina; L Sedel; G Guillemin Journal: Nat Biotechnol Date: 2000-09 Impact factor: 54.908
Authors: A A Sawyer; S J Song; E Susanto; P Chuan; C X F Lam; M A Woodruff; D W Hutmacher; S M Cool Journal: Biomaterials Date: 2009-01-21 Impact factor: 12.479
Authors: Ichiro Sekiya; Benjamin L Larson; Jussi T Vuoristo; Jian-Guo Cui; Darwin J Prockop Journal: J Bone Miner Res Date: 2003-12-16 Impact factor: 6.741
Authors: D P Mukherjee; A S Tunkle; R A Roberts; A Clavenna; S Rogers; D Smith Journal: J Biomed Mater Res B Appl Biomater Date: 2003-10-15 Impact factor: 3.368
Authors: Shaun W McLaughlin; Zhanwu Cui; Trevor Starnes; Cato T Laurencin; Ho-Man Kan; Qian Wu; Lakshmi S Nair Journal: J Mater Sci Mater Med Date: 2012-06-03 Impact factor: 3.896
Authors: Shalini V Gohil; Douglas J Adams; Peter Maye; David W Rowe; Lakshmi S Nair Journal: J Biomed Mater Res A Date: 2014-03-03 Impact factor: 4.396
Authors: Gregor Buehrer; Amelie Balzer; Isabel Arnold; Justus P Beier; Carolin Koerner; Oliver Bleiziffer; Andreas Brandl; Christian Weis; Raymund E Horch; Ulrich Kneser; Andreas Arkudas Journal: Tissue Eng Part A Date: 2014-11-07 Impact factor: 3.845
Authors: Tiffany N Vo; Adam K Ekenseair; Patrick P Spicer; Brendan M Watson; Stephanie N Tzouanas; Terrence T Roh; Antonios G Mikos Journal: J Control Release Date: 2014-12-05 Impact factor: 9.776